Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta-analysis of randomized controlled trials involving 2624 patients
Mohammad Tanashat, AlMothana Manasrah, Mohamed Abouzid
Topics & Concepts
EmpagliflozinDapagliflozinMedicineEjection fractionMeta-analysisHeart failurePlaceboCochrane LibraryInternal medicineConfidence intervalRandomized controlled trialCardiologyDiabetes mellitusType 2 diabetesEndocrinologyAlternative medicinePathologyDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsPancreatic function and diabetes